163 related articles for article (PubMed ID: 1523961)
21. [Leprosy control and multidrug therapy in Togo: problems and perspectives].
Edorh AA; Tignokpa N; David MT; Ihou E
Acta Leprol; 1992; 8(1):23-8. PubMed ID: 1523962
[TBL] [Abstract][Full Text] [Related]
22. Relapses in multibacillary leprosy patients after multidrug therapy.
Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a new fixed duration (12 weeks) multi-drug regimen of bactericidal drugs in multibacillary leprosy.
Tejasvi T; Khaitan BK; Khanna N; Pandhi RK; Singh MK
Indian J Lepr; 2006; 78(4):329-37. PubMed ID: 17402345
[TBL] [Abstract][Full Text] [Related]
24. Symposium on multidrug therapy in leprosy. 24-26 April 1986, Würburg, West Germany. Proceedings.
Lepr Rev; 1986; 57 Suppl 3():1-288. PubMed ID: 3573948
[No Abstract] [Full Text] [Related]
25. Dental and oral condition in leprosy patients from Serra, Brazil.
Souza VA; Emmerich A; Coutinho EM; Freitas MG; Silva EH; Merçon FG; Souza AC; Balla VA; Zandonadi E; Peixoto RR; Deps PD
Lepr Rev; 2009 Jun; 80(2):156-63. PubMed ID: 19743619
[TBL] [Abstract][Full Text] [Related]
26. [A trial of polychemotherapy of leprosy in the Dakar region. Initial observations on the acceptability of the protocols used].
Millan J; Bodian M; Naudin JC; Diouf B; Boucher P; Ndoye B; Grosset J
Acta Leprol; 1986; 4(1):19-35. PubMed ID: 3526792
[TBL] [Abstract][Full Text] [Related]
27. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
Boerrigter G; Pönnighaus JM; Fine PE; Wilson RJ
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):255-61. PubMed ID: 2071983
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation 7 to 9 years later of trials of polychemotherapy carried out in Senegal in patients with leprosy].
Millan J; Faure I; Diouf B; Languillon J
Acta Leprol; 1985; 3(2):95-102. PubMed ID: 3907256
[No Abstract] [Full Text] [Related]
29. [Survey of leprosy disabilities in patients treated with multiple drug therapy in Ivory Coast].
Tiendrebéogo A; Djakeaux DS; Assé H; Eba ME; Sica A
Acta Leprol; 1997; 10(3):151-8. PubMed ID: 9281294
[TBL] [Abstract][Full Text] [Related]
30. Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.
Honrado ER; Tallo V; Balis AC; Chan GP; Cho SN
Dermatol Clin; 2008 Apr; 26(2):221-9, vi. PubMed ID: 18346553
[TBL] [Abstract][Full Text] [Related]
31. Short-course multi-drug therapy for leprosy patients.
Puavilai S; Timpatanapong P
J Med Assoc Thai; 1989 Jan; 72(1):33-6. PubMed ID: 2656897
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of leprosy.
Krishnamurthy P
J Indian Med Assoc; 2006 Dec; 104(12):680-1, 685. PubMed ID: 17474284
[TBL] [Abstract][Full Text] [Related]
33. [The patient's face, a follow-up study of a leper].
Schirren C
Z Hautkr; 1984 Nov; 59(22):1507-12. PubMed ID: 6097062
[TBL] [Abstract][Full Text] [Related]
34. Leprosy in the WHO African region.
Daumerie D
World Health Stat Q; 1991; 44(1):16-22. PubMed ID: 2068820
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
Mysore V; al-Suwaid AR
Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369
[No Abstract] [Full Text] [Related]
36. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
37. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
[TBL] [Abstract][Full Text] [Related]
38. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
39. Relapses in paucibacillary leprosy after MDT--a clinical study.
Grugni A; Nadkarni NJ; Kini MS; Mehta VR
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
[TBL] [Abstract][Full Text] [Related]
40. Multidrug therapy--the pathway for global leprosy elimination.
al-Qubati Y; al-Kubati AS
Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
